Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Mar;56(1):186-92.
doi: 10.1097/GRF.0b013e31827feea4.

Neonatal Abstinence Syndrome: Treatment and Pediatric Outcomes

Affiliations
Free PMC article
Review

Neonatal Abstinence Syndrome: Treatment and Pediatric Outcomes

Beth A Logan et al. Clin Obstet Gynecol. .
Free PMC article

Abstract

Recent rise in rates of opiate replacement therapy among pregnant women have resulted in increasing number of infants requiring treatment for neonatal abstinence syndrome (NAS). Short-term and long-term developmental outcomes associated with prenatal opiate exposure are discussed, including symptoms and severity of NAS, and early cognitive and motor delays. Maternal and infant risk factors are discussed, and include patterns of maternal substance use during pregnancy, genetic risk, polysubstance exposure pharmacological treatment for NAS and breastfeeding. The importance of characterizing corollary environmental risk factors is also considered.

Similar articles

See all similar articles

Cited by 16 articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback